For OSCC, Sox2 expression is a controversial marker considering that some studies have reported Sox2 to be linked to lymph node metastasis and poor survival, while others have found increased Sox2 expression to improve prognosis [12, 13]. This evidence concerns the gene SOX2 and metastasis.